Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of bimekizumab in active psoriatic arthritis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Bimekizumab (bimekizumab)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2024-10-16